SCHEMBL14017679

SCHEMBL14017679

CC(C)(C)OC(=O)N[C@H]1CCCN(Cc2ccn3ncnc(Oc4ccc(N)cc4F)c23)C1

nearest known ligand 0.54

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 2/20 0.54
MET P08581 14/20 0.50
NTRK1 P04629 1/20 0.48
SCN9A Q15858 1/20 0.42
MAP4K4 O95819 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14017676 0.96 AAK1 (0.57) AAK1METNTRK1SCN9A
SCHEMBL14017677 0.96 AAK1 (0.57) AAK1METNTRK1SCN9A
SCHEMBL4811602 0.92 AAK1 (0.63) AAK1METNTRK1
SCHEMBL4810959 0.90 MET (0.53) AAK1METNTRK1
SCHEMBL4822868 0.86 MET (0.56) AAK1METNTRK1
SCHEMBL14017672 0.84 MET (0.55) AAK1METNTRK1
SCHEMBL14017710 0.84 MET (0.54) AAK1METNTRK1
SCHEMBL4817297 0.82 MET (0.61) AAK1METNTRK1
SCHEMBL4819894 0.78 MET (0.62) AAK1METNTRK1
SCHEMBL15946933 0.77 MET (0.54) AAK1METNTRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7439246-B2 Fused heterocyclic kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2008-10-21 US disclosed
US-7173031-B2 Pyrrolotriazine kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-02-06 US disclosed